{"id":3002,"date":"2016-08-04T16:50:52","date_gmt":"2016-08-04T16:50:52","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=16910"},"modified":"2016-08-04T16:50:52","modified_gmt":"2016-08-04T16:50:52","slug":"medical-marijuana-inc-ceo-interviewed-uptick-newswire-discusses-latin-market-expansion-portfolio-companies-kannaway-axim-biotech","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/08\/04\/medical-marijuana-inc-ceo-interviewed-uptick-newswire-discusses-latin-market-expansion-portfolio-companies-kannaway-axim-biotech\/","title":{"rendered":"Medical Marijuana, Inc. CEO Interviewed for Uptick Newswire; Discusses Latin Market Expansion, Portfolio Companies Kannaway and AXIM Biotech"},"content":{"rendered":"
San Diego, CA \u2013 Aug. 4, 2016<\/b> \u2013 <\/span>Medical Marijuana, Inc.<\/span><\/a> (OTC: MJNA) announced today that the Company\u2019s CEO Dr. Stuart Titus was interviewed by the <\/span>Uptick Network\u2019s Stock Day Radio Show<\/span><\/a> about expanding access to cannabidiol (CBD)-based products to people across Latin America, recent developments for its pharmaceutical and biotechnology investment portfolio companies, and investing in the booming cannabis industry.<\/span><\/p>\n \u201cOur mission is to change the way the world thinks about cannabis, which is why I\u2019m always grateful when the news media gives us an opportunity to talk about the plethora of benefits that our products can produce and the advancements our company and the cannabis industry as a whole are making to change people\u2019s lives around the world,\u201d Dr. Titus said.<\/span><\/p>\n The interview with Dr. Titus, conducted by Uptick Newswire\u2019s CEO Everett Jolly, includes a discussion about the cannabis industry gaining ground in Latin America and how <\/span>Medical Marijuana, Inc.<\/span><\/a> plans to further expand into the region as demand for its products continue increasing. Dr. Titus also discusses how the Company\u2019s <\/span>Real Scientific Hemp Oil-X\u2122 <\/span><\/a>(<\/span>RSHO-X<\/span><\/a>\u2122)<\/span> became the first-ever cannabis product approved by federal authorities for import into Mexico.<\/span><\/p>\n Dr. Titus also gives an update on how investment portfolio company Kannalife Sciences, Inc. (“Kannalife”) is creating intellectual property to treat diseases that affect the brain and the progress of investment portfolio company <\/span>AXIM Biotechnologies<\/span><\/a>\u2019<\/span> first-ever human clinical trials into the dermatological use of CBD for psoriasis and atopic dermatitis. Dr. Titus concludes with a discussion on current investment opportunities in the cannabis market and how <\/span>Medical Marijuana, Inc.\u2019s<\/span><\/a> diversified portfolio of cannabis companies and brands are capitalizing on the current cannabis revolution.<\/span><\/p>\n Dr. Titus will be speaking on Aug. 7 at 1 p.m. on “Cannabis and Medical Research,” <\/span>at the <\/span>Southern California Cannabis Conference and Expo<\/span><\/a> (SocalCCExpo)<\/span> at the San Diego Convention Center and on Aug. 25 at 9:00 a.m. on cannabis investing and current global industry trends at <\/span>The San Francisco Money Show\u2019s Cannabis Investing Symposium<\/span><\/a>.<\/span><\/p>\n Visit <\/span>here<\/span><\/a> for the full Uptick Network interview with Dr. Titus.<\/span><\/p>\n ###<\/span><\/p>\n About Medical Marijuana, Inc.<\/b><\/p>\n Our mission is to be the premier cannabis and hemp industry innovators, leveraging our\u00a0team of professionals to source, evaluate and purchase value-added companies and\u00a0products, while allowing them to keep their integrity and entrepreneurial spirit. We strive\u00a0to create awareness within our industry, develop environmentally-friendly, economically\u00a0sustainable businesses, while increasing shareholder value. For details on\u00a0Medical\u00a0Marijuana, Inc.\u2019s portfolio and investment companies, visit\u00a0<\/span>www.medicalmarijuanainc.com<\/span><\/a>.<\/span><\/p>\n To see Medical Marijuana, Inc.\u2019s video statement,\u00a0<\/span>click here<\/span><\/a>.\u00a0Shareholders are also encouraged to visit the\u00a0<\/span>Medical Marijuana, Inc. Shop<\/span><\/a>\u00a0for\u00a0discounted products.<\/span><\/p>\n FORWARD-LOOKING DISCLAIMER<\/i><\/b><\/p>\n This press release may contain certain forward-looking statements and information, as\u00a0defined within the meaning of Section 27A of the Securities Act of 1933 and Section\u00a021E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created\u00a0by those sections. This material contains statements about expected future events\u00a0and\/or financial results that are forward-looking in nature and subject to risks and\u00a0uncertainties. Such forward-looking statements by definition involve risks, uncertainties\u00a0and other factors, which may cause the actual results, performance or achievements of\u00a0Medical Marijuana, Inc. to be materially different from the statements made herein.<\/span><\/i><\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/i><\/b><\/p>\n These statements have not been evaluated by the FDA and are not intended to\u00a0diagnose, treat or cure any disease.<\/span><\/i><\/p>\n LEGAL DISCLOSURE<\/i><\/b><\/p>\n Medical Marijuana Inc. does not sell or distribute any products that are in violation of the\u00a0United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution\u00a0of medical marijuana-based products within certain international markets. Cannabidiol is\u00a0a natural constituent of hemp oil.<\/span><\/i><\/p>\n \u00a0<\/b><\/p>\n Public Relations Contact:<\/b><\/p>\n Andrew Hard<\/span><\/p>\n Chief Executive Officer<\/span><\/p>\n CMW Media<\/span><\/p>\n 888-829- 0070<\/span><\/p>\n andrew.hard@cmwmedia.com<\/span><\/a><\/p>\n www.cmwmedia.com<\/span><\/a><\/p>\n \u00a0<\/span><\/p>\n Corporate Business Contact:<\/b><\/p>\n Nicholas R. Massalas<\/span><\/p>\n Director of Business Development<\/span><\/p>\n Medical Marijuana, Inc.<\/span><\/p>\n OTC Symbol: MJNA<\/span><\/p>\n Toll Free: 888-OTC- MJNA\u00a0<\/span>(888-682- 6562<\/span><\/a>)<\/span><\/p>\n www.medicalmarijuanainc.com<\/span><\/a><\/p>\n www.facebook.com\/mjnainc<\/span><\/a><\/p>\n \u00a0<\/span><\/p>\n Investor Relations Contact:<\/b><\/p>\n EquiNet, LLC<\/span><\/p>\n Toll Free:\u00a0<\/span>(877) 964.6463<\/span><\/a><\/p>\n Office\/Direct:\u00a0(858) 264-6500<\/span><\/p>\n Email:\u00a0<\/span>info@equinet.us<\/span><\/a><\/p>\n